Molecular epidemiology and population immunity of SARS-CoV-2 in Guangdong (2022–2023) following a pivotal shift in the pandemic
Open Access
- 15 August 2024
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-12
Abstract
The SARS-CoV-2 Omicron variant sparked the largest wave of infections worldwide. Mainland China eased its strict COVID-19 measures in late 2022 and experienced two nationwide Omicron waves in 2023. Here, we investigated lineage distribution and virus evolution in Guangdong, China, 2022-2023 by comparing 5813 local viral genomes with the datasets from other regions of China and worldwide. Additionally, we conducted three large-scale serological surveys involving 1696 participants to measure their immune response to the BA.5 and XBB.1.9 before and after the corresponding waves. Our findings revealed the Omicron variants, mainly the BA.5.2.48 lineage, causing infections in over 90% of individuals across different age groups within a month. This rapid spread led to the establishment of widespread immunity, limiting the virus’s ability to further adaptive mutation and dissemination. While similar immune responses to BA.5 were observed across all age groups after the initial wave, children aged 3 to 11 developed a stronger cross immune response to the XBB.1.9 strain, possibly explaining their lower infection rates in the following XBB.1 wave. Reinfection with Omicron XBB.1 variant triggered a more potent neutralizing immune response among older adults. These findings highlight the impact of age-specific immune responses on viral spread in potential future waves.Keywords
Funding Information
- Guangdong Provincial Department of Science and Technology (2023A1515011927)
This publication has 41 references indexed in Scilit:
- Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variantsCell, 2024
- Virological characteristics of the SARS-CoV-2 JN.1 variantThe Lancet Infectious Diseases, 2024
- Knowledge and willingness toward SARS-CoV-2 rapid antigen testing among older adults in China: a nationwide cross-sectional studyAging Clinical and Experimental Research, 2023
- Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variantThe Lancet Infectious Diseases, 2023
- Characterisation of SARS-CoV-2 variants in Beijing during 2022: an epidemiological and phylogenetic analysisThe Lancet, 2023
- Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variantThe Lancet Infectious Diseases, 2023
- Prevention and control measures to further optimize COVID‐19 responseHealth Care Science, 2023
- Capturing noroviruses circulating in the population: sewage surveillance in Guangdong, China (2013–2018)Water Research, 2021
- COVID-19-neutralizing antibodies predict disease severity and survivalCell, 2021
- Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, ChinaCell, 2020